Literature DB >> 24752349

IL-17, a potential therapeutic target for Sjögren's syndrome?

Shan-Shan Liu1, Ye Ding, Ji-Quan Lou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24752349     DOI： 10.1007/s10067-014-2621-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  9 in total

1.  IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome.

Authors:  Alessia Alunno; Onelia Bistoni; Elena Bartoloni; Sara Caterbi; Barbara Bigerna; Alessia Tabarrini; Roberta Mannucci; Brunangelo Falini; Roberto Gerli
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

2.  Th17 cells play a critical role in the development of experimental Sjögren's syndrome.

Authors:  Xiang Lin; Ke Rui; Jun Deng; Jie Tian; Xiaohui Wang; Shengjun Wang; King-Hung Ko; Zhijun Jiao; Vera Sau-Fong Chan; Chak Sing Lau; Xuetao Cao; Liwei Lu
Journal:  Ann Rheum Dis       Date:  2014-02-26       Impact factor: 19.103

3.  Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome.

Authors:  X Tan; S Sun; Y Liu; T Zhu; K Wang; T Ren; Z Wu; H Xu; L Zhu
Journal:  Eye (Lond)       Date:  2014-03-07       Impact factor: 3.775

4.  Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome.

Authors:  Francesco Ciccia; Giuliana Guggino; Aroldo Rizzo; Riccardo Alessandro; Francesco Carubbi; AnnaRita Giardina; Paola Cipriani; Angelo Ferrante; Alessandra Cannizzaro; Roberto Giacomelli; Giovanni Triolo
Journal:  Rheumatology (Oxford)       Date:  2014-03-06       Impact factor: 7.580

5.  Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome.

Authors:  Francesco Ciccia; Giuliana Guggino; Aroldo Rizzo; Angelo Ferrante; Stefania Raimondo; AnnaRita Giardina; Francesco Dieli; Giuseppina Campisi; Riccardo Alessandro; Giovanni Triolo
Journal:  Ann Rheum Dis       Date:  2011-10-06       Impact factor: 19.103

6.  Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren's syndrome.

Authors:  Yunyun Fei; Wen Zhang; Dongfang Lin; Chen Wu; Mengtao Li; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang
Journal:  Clin Rheumatol       Date:  2014-01-14       Impact factor: 2.980

7.  Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.

Authors:  Sang Yeop Lee; Soo Jung Han; Sang Min Nam; Sang Chul Yoon; Ji Min Ahn; Tae-Im Kim; Eung Kweon Kim; Kyoung Yul Seo
Journal:  Am J Ophthalmol       Date:  2013-06-07       Impact factor: 5.258

8.  Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer.

Authors:  Cuong Q Nguyen; Hongen Yin; Byung Ha Lee; Wendy C Carcamo; John A Chiorini; Ammon B Peck
Journal:  Arthritis Res Ther       Date:  2010-12-23       Impact factor: 5.156

9.  Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.

Authors:  M Miletic; R Stojanovic; O Pajic; D Bugarski; S Mojsilovic; V Cokic; P Milenkovic
Journal:  Indian J Med Res       Date:  2012-04       Impact factor: 2.375
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.